Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-016179
Filing Date
2025-06-23
Accepted
2025-06-23 20:02:15
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3947
  Complete submission text file 0001641172-25-016179.txt   5346
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Issuer) CIK: 0001862150 (see all company filings)

EIN.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CINGULATE INC. 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address
Lawrence Bryan Jay (Reporting) CIK: 0002011767 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40874 | Film No.: 251066375